David Owens

CIK: 0001916664

Transaction Breakdown

Open Market Buys (P)7 (46.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (53.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NXL

Nexalin Technology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

NXL
Nexalin Technology, Inc.
Dec 19, 2025
Award(A)
Stock Option (right to buy)*
Direct
1M shares-
NXL
Nexalin Technology, Inc.
Sep 29, 2025
Award(A)
Direct
36.5K shares-
NXL
Nexalin Technology, Inc.
Sep 12, 2025
Award(A)
Stock Option (right to buy)
Direct
203.1K shares-
NXL
Nexalin Technology, Inc.
Sep 12, 2025
Award(A)
Stock Option (right to buy)
Direct
100K shares-
NXL
Nexalin Technology, Inc.
Feb 26, 2025
Award(A)
Stock Option (right to buy)
Direct
654.4K shares-
NXL
Nexalin Technology, Inc.
Feb 26, 2025
Award(A)
Stock Option (right to buy)
Direct
125K shares-
NXL
Nexalin Technology, Inc.
Feb 26, 2025
Award(A)
Stock Option (right to buy)
Direct
139.8K shares-
NXL
Nexalin Technology, Inc.
Feb 4, 2025
Purchase(P)
Direct
1K shares at avg. $3.10$3K
NXL
Nexalin Technology, Inc.
Feb 4, 2025
Purchase(P)
Direct
1K shares at avg. $2.98$3K
NXL
Nexalin Technology, Inc.
Jan 28, 2025
Purchase(P)
Direct
1.5K shares at avg. $2.70$4K
NXL
Nexalin Technology, Inc.
Jan 23, 2025
Purchase(P)
Direct
1K shares at avg. $2.70$3K
NXL
Nexalin Technology, Inc.
Jan 13, 2025
Purchase(P)
Direct
2K shares at avg. $2.50$5K
NXL
Nexalin Technology, Inc.
Dec 20, 2024
Purchase(P)
Direct
1K shares at avg. $2.75$3K
NXL
Nexalin Technology, Inc.
Nov 7, 2024
Award(A)
Stock Option (right to buy)
Direct
262.5K shares-
NXL
Nexalin Technology, Inc.
Oct 28, 2024
Purchase(P)
Direct
500 shares at avg. $2.19$1K

		Type	Shares	Price		Ownership
Dec 19, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)*	1,000,000	-	-	Direct
Sep 29, 2025	NXL Nexalin Technology, Inc.	Award(A)	36,459	-	-	Direct
Sep 12, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	203,125	-	-	Direct
Sep 12, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	100,000	-	-	Direct
Feb 26, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	654,363	-	-	Direct
Feb 26, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	125,000	-	-	Direct
Feb 26, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	139,821	-	-	Direct
Feb 4, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	1,000	$3.10	$3,100	Direct
Feb 4, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	1,000	$2.98	$2,980	Direct
Jan 28, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	1,500	$2.70	$4,050	Direct
Jan 23, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	1,000	$2.70	$2,700	Direct
Jan 13, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	2,000	$2.50	$5,000	Direct
Dec 20, 2024	NXL Nexalin Technology, Inc.	Purchase(P)	1,000	$2.75	$2,750	Direct
Nov 7, 2024	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	262,500	-	-	Direct
Oct 28, 2024	NXL Nexalin Technology, Inc.	Purchase(P)	500	$2.19	$1,095	Direct

1-15 of 15 transactions

About Owens David

Owens David (SEC CIK 0001916664) files insider reports with the SEC as Chief Medical Officer of Nexalin Technology, Inc. (NXL).

Signal8 holds 10 ownership filings by Owens David (9 Form 4, 1 Form 5), filed between Oct 30, 2024 and Dec 23, 2025. Those filings report 15 transactions, from Oct 28, 2024 to Dec 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Owens David's filings is in ATLANTA, GA.

Recent filings by Owens David

Dec 19, 2025: Grant or award of NXL derivative securities (Form 4, code A).
Sep 29, 2025: Grant or award of NXL shares (Form 4, code A).
Sep 12, 2025: Grants or awards of NXL derivative securities (2 lines, Form 4, code A).
Feb 26, 2025: Grants or awards of NXL derivative securities (3 lines, Form 4, code A).
Feb 4, 2025: Open-market purchases of NXL shares (2 lines, Form 4, code P).

Other insiders filing for Nexalin Technology, Inc. (NXL)

White Mark, President and CEO
Van Fleet Justin, CFO
Shelton Carolyn Hamby, Senior VP
Hu Ben, Director
Kazden Alan, Director
OSSER LEONARD, 10% Owner

How to read Form 4 transaction codes